title: L38. How to treat primary vasculitis of the central nervous system.
authors: Mount Sinai Hospital, University of Toronto, Division of Rheumatology, Department of Medicine, Toronto, ON, Canada. cpagnoux@mtsinai.on.ca
authors: Christian
authors: C
authors: Pagnoux
authors: Hubert
authors: H
authors: de Boysson
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008134:Long-Term Care; D009460:Neurologic Examination / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D055502:Secondary Prevention; D015996:Survival Rate; D020293:Vasculitis, Central Nervous System / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D003520:Cyclophosphamide